AI-generated summary
The authors studied 538 pediatric patients receiving repeated low-level red-light therapy for myopia, with at least one year of follow-up, using machine learning models. They report that an XGBoost model predicted outcomes with an AUC of 0.90 to 0.92, and that changes in axial length and choroidal thickness were the key predictors. The abstract does not describe a control group.
- Participants
- 538
- Who or what was studied
- Pediatric patients with myopia who underwent repeated low-level red-light therapy in a multicenter cohort study
- Limits stated in the abstract
- The abstract does not describe a control group, and the model's predictive performance is reported only as retrospective cohort results without external validation details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.